Western blot analysis further confirmed that the treatment with the CM from HL60 as well as AML cell lines (U397 and KG1A) and primary AML cells increased HDAC3 protein levels in HS-5 cells (Fig. 2D–G and Fig. S2D). The gene discussed is HDAC3; the disease is acute myeloid leukemia.